CD8A and central nervous system cancer: A study of C57BL/6 mice–bearing syngeneic GL-261 gliomas also demonstrated a survival advantage when an HSV virus–expressing mIL-12 initiated a Th1 response and CD8+ cell influx compared with the parent virus (Parker et al., 2000).